Institutional Support

Professor Longo’s research results have been published in top scientific, peer reviewed journal like Cell, Nature, Science, Journal of Translational Medicine, and covered by top global media including CNN, The New York Times and the BBC.

State of the art research and development and pre-clinical and clinical trials for Prolon® were conducted at the University of Southern California’s Longevity Institute and Diabetes and Obesity Research Institute, and sponsored by the National Cancer Institutes (NCI) and National Institute on Aging (NIA) of the National Institutes of Health (NIH).